Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir

Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir

Background: The aim of this study was to assess the long-term efficacy and safety of first-line treatment with once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors (NRTIs). Methods: A total of 272 antiretroviral-naive patients with a CD4+ T-cell count of 200-350 cells...

Full description

Saved in:
Bibliographic Details
Main Authors: Jintanat Ananworanich, Angele Gayet-Ageron, Kiat Ruxrungtham, Ploenchan Chetchotisakd, Wisit Prasithsirikul, Sasisopin Kiertiburanakul, Warangkana Munsakul, Phitsanu Raksakulkarn, Somboon Tansuphasawadikul, Michelle LeBraz, Thidarat Jupimai, Sasiwimol Ubolyam, Malte Schutz, Bernard Hirschel
Other Authors: The HIV Netherlands Australia Thailand Research Collaboration
Format: Article
Published: 2018
Subjects:
Medicine
Pharmacology, Toxicology and Pharmaceutics
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/19597
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University

Internet

https://repository.li.mahidol.ac.th/handle/123456789/19597

Similar Items